Medpace Holdings, Inc. (MEDP): Price and Financial Metrics


Medpace Holdings, Inc. (MEDP)

Today's Latest Price: $70.50 USD

2.05 (2.99%)

Updated Apr 2 12:32pm

Add MEDP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 66 in Medical - Services

See all "A" rated Strong Buy stocks

MEDP Stock Summary

  • MEDP's went public 3.64 years ago, making it older than just 12% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of -43.29%, Medpace Holdings Inc's debt growth rate surpasses only 6.65% of about US stocks.
  • As for revenue growth, note that MEDP's revenue has grown 22.19% over the past 12 months; that beats the revenue growth of 78.85% of US companies in our set.
  • Stocks that are quantitatively similar to MEDP, based on their financial statements, market capitalization, and price volatility, are ASM, CELH, HMSY, EPAM, and IPI.
  • Visit MEDP's SEC page to see the company's official filings. To visit the company's web site, go to www.medpace.com.
MEDP Daily Price Range
MEDP 52-Week Price Range

MEDP Stock Price Chart More Charts


MEDP Price/Volume Stats

Current price $70.50 52-week high $109.09
Prev. close $68.45 52-week low $52.84
Day low $67.00 Volume 71,320
Day high $72.27 Avg. volume 325,043
50-day MA $86.25 Dividend yield N/A
200-day MA $79.06 Market Cap 2.57B

Medpace Holdings, Inc. (MEDP) Company Bio


Medpace, Inc. operates as a contract research organization that provides research based drug and medical device development services. The company was founded in 1992 and is based in Cincinnati, Ohio.

MEDP Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$70.50$145.7199%

Below please find a table outlining a discounted cash flow forecast for MEDP, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Medpace Holdings Inc ranked in the 57th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 99.67%. The most interesting components of our discounted cash flow analysis for Medpace Holdings Inc ended up being:

  • Interest coverage, a measure of earnings relative to interest payments, is 80.61; that's higher than 92.35% of US stocks in the Healthcare sector that have positive free cash flow.
  • The business' balance sheet suggests that 2% of the company's capital is sourced from debt; this is greater than only 6.49% of the free cash flow producing stocks we're observing.
  • MEDP's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 61.62% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%95%
1%97%
2%99%
3%101%
4%102%
5%104%

Want more companies with a valuation profile/forecast similar to that of Medpace Holdings Inc? See IART, EBS, IONS, UNH, and PDEX.


MEDP Latest News Stream


Event/TimeNews Detail
Loading, please wait...

MEDP Latest Social Stream


Loading social stream, please wait...

View Full MEDP Social Stream

MEDP Price Returns

1-mo -22.59%
3-mo -14.58%
6-mo -12.63%
1-year 13.58%
3-year 132.21%
5-year N/A
YTD -16.13%
2019 58.81%
2018 45.97%
2017 0.53%
2016 N/A
2015 N/A

Continue Researching MEDP

Here are a few links from around the web to help you further your research on Medpace Holdings Inc's stock as an investment opportunity:

Medpace Holdings Inc (MEDP) Stock Price | Nasdaq
Medpace Holdings Inc (MEDP) Stock Quote, History and News - Yahoo Finance
Medpace Holdings Inc (MEDP) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8062 seconds.